company background image
ABERA

Abera Bioscience NGM:ABERA Stock Report

Last Price

kr5.70

Market Cap

kr66.0m

7D

2.3%

1Y

-69.8%

Updated

06 Dec, 2022

Data

Company Financials
ABERA fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

ABERA Stock Overview

Abera Bioscience AB, a platform and vaccine development company, develops vaccines and immunotherapies based on its proprietary vaccine delivery platform worldwide.

Abera Bioscience AB Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Abera Bioscience
Historical stock prices
Current Share Pricekr5.70
52 Week Highkr19.80
52 Week Lowkr3.90
Beta0
1 Month Change36.69%
3 Month Change14.11%
1 Year Change-69.76%
3 Year Changen/a
5 Year Changen/a
Change since IPO-48.42%

Recent News & Updates

We're Not Very Worried About Abera Bioscience's (NGM:ABERA) Cash Burn Rate

Nov 03
We're Not Very Worried About Abera Bioscience's (NGM:ABERA) Cash Burn Rate

We Think Abera Bioscience (NGM:ABERA) Can Afford To Drive Business Growth

Jul 21
We Think Abera Bioscience (NGM:ABERA) Can Afford To Drive Business Growth

Recent updates

We're Not Very Worried About Abera Bioscience's (NGM:ABERA) Cash Burn Rate

Nov 03
We're Not Very Worried About Abera Bioscience's (NGM:ABERA) Cash Burn Rate

We Think Abera Bioscience (NGM:ABERA) Can Afford To Drive Business Growth

Jul 21
We Think Abera Bioscience (NGM:ABERA) Can Afford To Drive Business Growth

Shareholder Returns

ABERASE BiotechsSE Market
7D2.3%-0.2%0.9%
1Y-69.8%-19.9%-24.6%

Return vs Industry: ABERA underperformed the Swedish Biotechs industry which returned -15% over the past year.

Return vs Market: ABERA underperformed the Swedish Market which returned -21.1% over the past year.

Price Volatility

Is ABERA's price volatile compared to industry and market?
ABERA volatility
ABERA Average Weekly Movement12.2%
Biotechs Industry Average Movement8.2%
Market Average Movement7.3%
10% most volatile stocks in SE Market12.5%
10% least volatile stocks in SE Market4.5%

Stable Share Price: ABERA is more volatile than 75% of Swedish stocks over the past 3 months, typically moving +/- 12% a week.

Volatility Over Time: ABERA's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of Swedish stocks.

About the Company

FoundedEmployeesCEOWebsite
20125Maria Alrikssonhttps://www.aberabio.com

Abera Bioscience AB, a platform and vaccine development company, develops vaccines and immunotherapies based on its proprietary vaccine delivery platform worldwide. Its vaccine development platform is BERA, which is based on outer membrane vesicles derived from genetically optimized gram-negative bacteria. The company was founded in 2012 and is based in Stockholm, Sweden.

Abera Bioscience AB Fundamentals Summary

How do Abera Bioscience's earnings and revenue compare to its market cap?
ABERA fundamental statistics
Market Capkr65.98m
Earnings (TTM)-kr17.46m
Revenue (TTM)kr2.24m

29.4x

P/S Ratio

-3.8x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
ABERA income statement (TTM)
Revenuekr2.24m
Cost of Revenuekr0
Gross Profitkr2.24m
Other Expenseskr19.70m
Earnings-kr17.46m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-1.51
Gross Margin100.00%
Net Profit Margin-777.68%
Debt/Equity Ratio0.0%

How did ABERA perform over the long term?

See historical performance and comparison